Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is a publicly traded the market company. As of October 28, 2026, ELOX trades at $13.23 with a market cap of $45.26M and a P/E ratio of -0.85. ELOX moved -1.52% today. Year to date, ELOX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $23.40. Analyst consensus is strong buy with an average price target of $38.25. Rallies surfaces ELOX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ELOX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ELOX recently traded at $13.23. Market cap is $45.26M. P/E ratio is -0.85. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $13.23 |
| Market Cap | $45.26M |
| P/E Ratio | -0.85 |
| EPS | $-16.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.40 |
| 52-Week Low | $0.00 |
| Volume | 10.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-36.06M |
| Gross Margin | 0.00% |
5 analysts cover ELOX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.25.